Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: design and baseline characteristics of the STOP-C trial

American Journal of Epidemiology(2024)10.1093/aje/kwae430Source: DataRank Database

A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: design and baseline characteristics of the STOP-C trial is a research paper published in American Journal of Epidemiology (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04652804

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: bronzeTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Bryan Lau ORCID,Stephan Ehrhardt,Allison M. McFall ORCID,Mihili P Gunaratne,Jiban Baishya ORCID

Live enrichment

PubMed:39572371 OpenAlex:https://openalex.org/W4404609766

NIDA NIH HHS

Grant: K24 DA035684

NIAID NIH HHS

Grant: P30 AI094189

NIAID NIH HHS

Grant: R01 AI145555

NIDA NIH HHS

Grant: DP2 DA040244

NIH HHS

Grant: K24DA035684, P30AI094189, R01AI145555, R01DA041034, DP2DA040244

NIDA NIH HHS

Grant: R01 DA041034

NIAID NIH HHS

Grant: T32 AI102623

FWCI

0.00

Citation Percentile

0.3%

bronze

journalhttps://academic.oup.com/aje/article-pdf/194/10/2986/60541406/kwae430.pdf

journalhttps://doi.org/10.1093/aje/kwae430

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39572371

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12527261

Fields of Study

Hepatitis C virus researchHumansIndiaSubstance Abuse, IntravenousAntiviral AgentsMaleAdultFemaleHepatitis CTreatment OutcomeMiddle AgedSustained Virologic ResponseMedication AdherenceRandomized Controlled Trials as Topic

MeSH Terms

Sustained Virologic ResponseAdultAntiviral AgentsFemaleHepatitis CHumansIndiaMaleMiddle AgedSubstance Abuse, IntravenousRandomized Controlled Trials as TopicTreatment OutcomeMedication Adherence

Keywords

MedicineRandomized controlled trialHepatitis CClinical trialInternal medicinepeople who inject drugs

Sustainable Development Goals

SDG 0: Good health and well-being